Google
Trusted Resources: People & Places
Healthcare providers, researchers, and advocates
Yogen Saunthararajah, MD
Researcher Professor of Medicine
Cleveland Clinic Main Campus
9500 Euclid Avenue
Cleveland, Ohio, United States
Yogen Saunthararajah, MD, is a staff in the department of Hematologic Oncology and Blood Disorders at Cleveland Clinic, a professor of medicine, and co-leader of the developmental therapeutics program of the Case Comprehensive Cancer Center.
His clinical and research interests include acute myeloid leukemia, myelodysplastic syndrome, sickle cell disease/anemia, thalassemia, leukemia, benign hematology, myelodysplasia, cancer, leukopenia, aplastic anemia.
Dr. Yogen developed an Epigenetic Platform that has the potential to identify and eliminate the “road blocks” that prevent cancer cells from becoming specialized, non-dividing cells. According to him, the methodology can be applied to some of the most common and most debilitating genetic disorders in the world, including sickle cell disease and beta thalassemia.
+myBinderRelated Content
-
Elliott Vichinsky, MDElliott Vichinsky, MD diagnoses and trea...
-
Doris Duke Charitable Foundation awards grant to Critical Path InstituteIn a continuing effort to spur advance...
-
Eric E. Bouhassira, PhDDr. Eric E. Bouhassira joined the Albert...
-
East Carolina University Comprehensive Sickle Cell CenterEast Carolina University Comprehensive S...
-
Increased acute care utilization in a prospective cohort of adults with sickle cell diseaseThe ESCAPED (Examining Sickle Cell Acute...
-
Improving Quality of Care for Sickle Cell Patients in the Pediatric Emergency DepartmentOBJECTIVE: The aim of this study was to ...
-
@juliemakaniScientist|Doctor - Sickle Cell Disease f...
